ArticleFrontiers in immunology2022

CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cells.

Julie Brault et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.